NIRVANA
Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liquid Biopsy
More Information
- Trial Status
- Accepting patients
- Enrollment
- 88 patients (estimated)
- Sponsors
- Columbia University Medical Center
- Collaborators
- Hope Foundation
- Trial Type
- Observational
- Last Update
- 2 weeks ago
- SparkCures ID
- 1925
- NCT Identifier
- NCT05625971
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.